Great news to see on World Hypopara Awareness Day 2022! ”Amolyt Pharma announces positive results from phase 2a trial of AZP-3601 for the treatment of hypoparathyroidism.” Read more here https://amolytpharma.com/…/amolyt-pharma-announces…/ Positive results from new hypopara drug
Great news to see on World Hypopara Awareness Day 2022! ”Amolyt Pharma announces positive results from phase 2a trial of AZP-3601 for the treatment of hypoparathyroidism.” Read more here https://amolytpharma.com/…/amolyt-pharma-announces…/